cc-292 and Leukemia

cc-292 has been researched along with Leukemia* in 1 studies

Other Studies

1 other study(ies) available for cc-292 and Leukemia

ArticleYear
Structural optimization of diphenylpyrimidine derivatives (DPPYs) as potent Bruton's tyrosine kinase (BTK) inhibitors with improved activity toward B leukemia cell lines.
    European journal of medicinal chemistry, 2017, Jan-27, Volume: 126

    Topics: Agammaglobulinaemia Tyrosine Kinase; Cell Line, Tumor; Humans; Leukemia; Molecular Docking Simulation; Protein Conformation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Structure-Activity Relationship

2017